Combined therapy with dapagliflozin and entresto offers an additional benefit on improving the heart function in rat after ischemia-reperfusion injury
Background: This study tested whether combined dapagliflozin and entresto treatment would be superior to either one alone for preserving the left-ventricular ejection-fraction (LVEF) in rat after ischemia-reperfusion (IR) injury. Methods: Cell culture using H9C2 cells and IR injury in rat with dapag...
Main Authors: | Sheung-Fat Ko, Pei Hsun Sung, Chih Chao Yang, John Y. Chiang, Hon Kan Yip |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-06-01
|
Series: | Biomedical Journal |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2319417022000981 |
Similar Items
-
Dapagliflozin alleviates myocardial ischemia/reperfusion injury by reducing ferroptosis via MAPK signaling inhibition
by: Weixiang Chen, et al.
Published: (2023-02-01) -
Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK
by: Kun-Ling Tsai, et al.
Published: (2021-02-01) -
Effects of dapagliflozin on myoglobin efflux from cardiomyocyte during myocardial ischemia/reperfusion in anesthetized rats
by: Tomohiro Hayashida, et al.
Published: (2024-07-01) -
Cost-Effectiveness and Formulary Evaluation: Imaginary Worlds and Entresto Claims in Heart Failure
by: Paul C Langley
Published: (2016-09-01) -
Effect of dapagliflozin on ferroptosis through the gut microbiota metabolite TMAO during myocardial ischemia–reperfusion injury in diabetes mellitus rats
by: Lian Wang, et al.
Published: (2024-06-01)